New Delhi: Zydus Cadila medicine company on Saturday said it had received approval from US health regulators to market injection of Dekitabine, used to treat certain types of cancer, in the American market.
The company has received the final approval of the US Food and Medicine Administration (USFda) to Decitabine for injection in the strength of 50 mg / single vial vial dose, Zydus Cadila said in a statement.
Decitabine is used to treat myelodysplastic syndrome, specific blood type or cancer bone cancer.
Drugs will be produced in group injection manufacturing facilities, the drug maker said.
Zydus Group now has 326 agreements and has so far submitted more than 400 new drug applications (Andas) since the start of the archiving process in 2003-04, he added.
Ludhiana: The police have submitted FIR to four identified and at least 40 unknown attackers…
Sonīpat / Ludhiana / Ambala: Actor Punjabi - Activist Activist Deep Sidhu, who died in…
PATIALA / MANSA / BARNALA: Attacking Prime Minister Narendra Modi and AAP National Convener Kejriawal,…
Jalandhar: BJP and AAM AAM AADMI parties are one party, Secretary General of the Ajay…
Ludhiana: Minister of Union Culture Meenakshi Lekhi while campaigning to support the BJP candidate from…
Machhiwara (Ludhiana): AAM AAM AADMI Party (AAP) Head of Punjab Candidate and Members of Parliament…